Biberach, Germany

Juergen Schnaubelt

This inventor holds 1 USPTO granted patent. Top assignee: Boehringer Ingelheim Kg. Active years: 2000.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Juergen Schnaubelt. Retrieved from https://idiyas.com/inventor/juergen-schnaubelt-r1tqpid0

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2000

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Juergen Schnaubelt: Innovator in Pharmaceutical Chemistry

Introduction

Juergen Schnaubelt is a notable inventor based in Biberach, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds. His work focuses on creating innovative solutions that can enhance therapeutic options in medicine.

Latest Patents

Juergen Schnaubelt holds a patent for a process for preparing pharmaceutically useful norbenzomorphane derivatives. This invention relates to a new method for synthesizing norbenzomorphane derivatives of general formula 1. His innovative approach aims to improve the efficiency and effectiveness of pharmaceutical preparations.

Career Highlights

Throughout his career, Juergen has been associated with Boehringer Ingelheim KG, a leading global pharmaceutical company. His role at the company has allowed him to work on cutting-edge research and development projects that contribute to advancements in healthcare.

Collaborations

Juergen Schnaubelt has collaborated with esteemed colleagues such as Hanfried Baltes and Matthias Grauert. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise in the field of pharmaceutical innovation.

Conclusion

Juergen Schnaubelt's contributions to pharmaceutical chemistry exemplify the impact of innovative thinking in medicine. His work continues to inspire advancements that can lead to better health outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…